NCT04175262
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada
Clinical trial condition
Kidney Neoplasms
Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.
1,142 public trials
219 recruiting studies
Kidney Neoplasms trial results
NCT00716625
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
Not specified
NCT03841110
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
- Locations
-
- UCSD Moores Cancer Center San Diego, California, United States
- University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
- Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT02850809
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- CHU de Bordeaux - Pellegrin Bordeaux, France
- CHU de Grenoble Grenoble, France
- CHRU de Lille - Hôpital Claude HURIEZ Lille, France
- Hospices Civils de Lyon Lyon, France
NCT03548467
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
- Locations
-
- Charité Research Organisation, Campus Benjamin Franklin Berlin, Germany
- Krankenhaus Nordwest gGmbH Frankfurt, Germany
- Martin-Luther-Universität Halle-Wittenberg, Universitätsklinikum Halle (Saale) Halle, Germany
- University Hospital Heidelberg, NCT, Im Neuenheimer Feld 460 Heidelberg, Germany
NCT03758781
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +41 more
- Locations
-
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT02853344
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
Not specified
NCT05800106
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +28 more
- Locations
-
- Affiliated Hospital of Changchun University of Traditional Chinese Medicine Changchun, Jilin, China
Completed
Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib
NCT04076787
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada
NCT02732665
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Sahlgrenska University Hospital Gothenburg, Sweden